Screener
Prime Medicine PRME Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
FAQ
- What is Prime Medicine's retained earnings?
- Prime Medicine (PRME) reported retained earnings of -$979.59M in Q2 2026.
- How has Prime Medicine's retained earnings changed year-over-year?
- Prime Medicine's retained earnings decreased by 23.7% year-over-year, from -$791.69M to -$979.59M.
- What is the long-term trend for Prime Medicine's retained earnings?
- Over 4 years (2021 to 2025), Prime Medicine's retained earnings has grown at a 50.9% compound annual growth rate (CAGR), from -$171.38M to -$888.35M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Prime Medicine's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude